Nuveen
QUIT icon

Nuveen’s Achieve Life Sciences QUIT Stock Holding History

Nuveen’s Portfolio QUIT Stock Details QUIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.48M Sell
182,510
-8,640
-5% -$61.8K ﹤0.01% 2793
2026
Q2 		$1.25M Buy
+191,150
New +$911K ﹤0.01% 2833
2025
Q2 		– Sell
-46,668
Closed -$125K – 3275
2025
Q1 		$125K Hold
46,668
– – ﹤0.01% 3197
2024
Q4 		$164K Hold
46,668
– – ﹤0.01% 3234
2024
Q3 		$221K Hold
46,668
– – ﹤0.01% 3208
2024
Q2 		$219K Buy
+46,668
New +$225K ﹤0.01% 3198

Other funds holding QUIT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

Nuveen's QUIT Position: Q3 2026 in Review

Nuveen reduced its Achieve Life Sciences (QUIT) stake by 4.5% in Q3 2026, selling an estimated $61.8K and leaving 182,510 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2793.

Nuveen first reported a position in QUIT in Q2 2024 and has held it in 6 quarters since. 42 funds tracked by Wall St. Rank hold QUIT as of Q3 2026.

  • Nuveen held 182,510 shares of Achieve Life Sciences worth $1.48M as of Q3 2026.
  • Nuveen sold 8,640 Achieve Life Sciences shares in Q3 2026, an estimated $61.8K.
  • Achieve Life Sciences made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #2793 holding.
  • Nuveen first reported a position in Achieve Life Sciences in Q2 2024 and has held it in 6 quarters since.
  • 42 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.